Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats. - Wikidata - awgldk - TriplyDB

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

http://www.wikidata.org/entity/Q35207833

about

Cardiac endothelium-myocyte interaction: clinical opportunities for new heart failure therapies regardless of ejection fraction Neuregulin as a heart failure therapy and mediator of reverse remodeling ErbB2 signaling at the crossing between heart failure and cancer SIRT1 protects against myocardial ischemia-reperfusion injury via activating eNOS in diabetic rats.A new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic rats Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats.Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling.Signalling between microvascular endothelium and cardiomyocytes through neuregulin.Structural changes in the myocardium during diabetes-induced cardiomyopathy.Novel drug targets in clinical development for heart failure.The roles of neuregulin-1 in cardiac development, homeostasis, and disease.New Targets in the Drug Treatment of Heart Failure.Diabetic cardiomyopathy: role of the E3 ubiquitin ligase.Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.Nox2 contributes to cardiac fibrosis in diabetic cardiomyopathy in a transforming growth factor-β dependent manner.Role of tissue transglutaminase in the pathogenesis of diabetic cardiomyopathy and the intervention effect of rutin.Inhibitory actions of the NRG-1/ErbB4 pathway in macrophages during tissue fibrosis in the heart, skin, and lung.Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes.Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective.Neuregulin improves response to glucose tolerance test in control and diabetic rats.Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension

P2860

Q26853363-0CC8F863-8C25-4FB2-A9AE-0A6039286ADA Q26991903-B1F36651-1E36-4313-8365-AEDE35B2D758 Q28075244-D49D9C93-4F82-4492-AE98-008D9CD9FBA6 Q36200567-9C8F4B0B-A9A2-49C0-AA6A-ABDF8A68A107 Q36307139-5EA9C613-8F9C-432E-84F9-49C2EE41E8E5 Q36320281-8C782696-6234-41B8-9B00-6615FF429787 Q36741562-18DC6021-DE56-44BD-BCA1-D39FDF1F45F9 Q36775652-74465A36-0E64-48F4-9BF6-53FE5D479739 Q37288691-DD24C71A-1C52-47F9-B9C1-EBCC66C96115 Q37698825-0DC23E0A-6289-4432-88E3-D05887697F80 Q37707158-C2739521-0D82-49B1-BAA6-CFED0938B506 Q38087253-36B44A8A-2593-429F-AE77-E1E4075AB856 Q38202895-CFEC3D9B-D8AE-4BAA-9D2E-C1476E0FA893 Q38448410-B15B6D7C-AA72-459A-A99E-D364AA375969 Q38667210-707A3CBB-F74C-44D7-81B8-37CA9AAEDA0E Q38687425-8BF2F3AE-08DF-4F5E-9215-4E1F8CBA55D7 Q41939381-A463DB3D-CF5F-406B-B90E-495F5AE2AE23 Q42061949-54B65545-AC86-40ED-834A-8E3CBCC1F428 Q43180714-BAFF0B49-A262-435F-A64B-CCC0B6D10FA5 Q47931199-0D6FD0F1-4CD2-425E-A4A2-78DD496F226E Q50223516-1A927C65-F4DE-4B31-94F9-4542AF56E180 Q51760757-062EF473-3344-4C6E-A8C5-24DFCB2C08F9 Q54225414-41647332-CC2F-4D1B-87F5-7F2B505FAF0B Q57805025-AA760791-6084-476D-B06F-8FD9AA3DCCA9

P2860

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

http://www.wikidata.org/entity/Q35207833

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

@ast

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

@en

type

label

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

@ast

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

@en

prefLabel

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

@ast

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

@en

P1433

Q35207833-AD4E279D-42F6-45F2-9D97-A8C021C614D4

P1476

Q35207833-50745F1A-9411-489F-86C9-B27DE47FF5E0

P2093

Q35207833-1177176D-5600-449D-9855-58F9DC85D527

Q35207833-2CC2F39F-2D73-4269-BB6A-AFF305AB5583

Q35207833-37F8EF04-6895-455C-AAFE-3C72787DCEBC

Q35207833-3DA02C36-3B94-4FD0-AB0F-5238C01A3DE4

Q35207833-75A9FD51-EAF0-436A-A0B0-4588417D749B

Q35207833-83BADB8B-6498-4C7A-87A7-1D5CAA3D95A9

Q35207833-9A8DAE2A-55F0-492B-BC75-EB943FA9D79B

Q35207833-B19BF25B-E10C-4354-81E1-C4391897FA9C

Q35207833-C2489D09-CE25-4E5A-8C0F-B949C18DF438

Q35207833-C6E915E6-7EF9-4104-A92F-D05F358ABFEA

P2860

Q35207833-144EB0B9-38BA-4CE3-A5B8-B421E52718A9

Q35207833-186DD098-C0DF-47CA-9113-1B5E2CCA02A6

Q35207833-2C7047BB-2D6D-4AA1-B695-2847C4516028

Q35207833-354DD9C0-ECD0-4C66-8C1D-117BB3891F6A

Q35207833-377673F7-BC1D-4C92-B963-F8A490EB8DF2

Q35207833-3A34B7BA-0BF4-4AD8-87C3-34CC8F39227E

Q35207833-443F9B74-06D7-4460-A803-C4BC0E46CCAD

Q35207833-6DDD6BDC-C1DE-4ADA-97D6-7B6F1A9FA652

Q35207833-7B959B94-DFB4-4CC3-A618-4385F094ADFF

Q35207833-7E9B742A-5F86-441B-A84D-C99C7EF70548

P2888

Q35207833-C3EDD48C-A508-471A-9A01-CDC4F9C79B97

P304

Q35207833-812998F2-A367-466E-9933-3427EEED92BD

P31

Q35207833-9DCAB85D-142E-4498-899B-8F2867058A78

P356

Q35207833-2193DAC7-56A6-41DF-B8F4-FDBCF879868E

P407

Q35207833-55780920-5C86-4A91-9B43-579F451F7CD2

P478

Q35207833-E76D5F79-5923-43FB-916D-C902791F0D3F

P577

Q35207833-BA0A31C5-A7DC-4F3D-9B38-B495BBBAE58E

P5875

Q35207833-C614F524-707D-4D44-8018-73565EF086DD

P6179

Q35207833-19ACDDF0-3EFF-48AD-BB9F-01747E056255

P698

Q35207833-EFD79039-1DB4-4D18-8C89-812816BF3F9C

P932

Q35207833-DF16A9E7-6AAA-49D0-9057-A326076EC3B5

P356

1475-2840-10-69

P1433

Cardiovascular Diabetology

P1476

Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

@en

P2093

Bingong Li

http://www.w3.org/2001/XMLSchema#string

Jian Xiao

http://www.w3.org/2001/XMLSchema#string

Jingtian Peng

http://www.w3.org/2001/XMLSchema#string

Menghong Wang

http://www.w3.org/2001/XMLSchema#string

Ting Kang

http://www.w3.org/2001/XMLSchema#string

Xin Huang

http://www.w3.org/2001/XMLSchema#string

Yong Li

http://www.w3.org/2001/XMLSchema#string

Yunfeng Wei

http://www.w3.org/2001/XMLSchema#string

Zeqi Zheng

http://www.w3.org/2001/XMLSchema#string

Zhe Li

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

Diabetic cardiomyopathy, causes and effects.

Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy

ERBB receptor activation is required for profibrotic responses to transforming growth factor beta.

Following nerve injury neuregulin-1 drives microglial proliferation and neuropathic pain via the MEK/ERK pathway.

ErbB receptors: directing key signaling networks throughout life.

Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.

Diabetic cardiomyopathy revisited.

P2888

1475-2840-10-69

P304

69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-10-69

http://www.w3.org/2001/XMLSchema#string

P407

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51529504

http://www.w3.org/2001/XMLSchema#string

P6179

1034640764

http://www.w3.org/2001/XMLSchema#string

P698

21798071

http://www.w3.org/2001/XMLSchema#string

P932

3170868

http://www.w3.org/2001/XMLSchema#string